survey the relationship between cognitive emotion regulation (CER) with cognitive performance and physiological indices
Not Applicable
Recruiting
- Conditions
- Condition 1: Cognitive Emotion Regulation (CER). Condition 2: Cognitive Performance. Condition 3: Physiological Indices.
- Registration Number
- IRCT20191228045922N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 40
Inclusion Criteria
Fars Combined Cycle Power Plant Control Room Staff
Being at least 24 years old
Having at least 4 years of work experience
Exclusion Criteria
history of neurosurgery
history of mental illness and related medications
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cognitive Performance: Mental performance 1 hour after intervention. Timepoint: in both control and intervention group, at the end of the experiment. Method of measurement: computerized cognitive tests (Cambridge Neuropsychological Test Automated Battery: CANTAB).;Physiological indices: Heart rate, respiration and electromyography. Timepoint: during the experiment. Method of measurement: Polygraphy and HEG.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What neural correlates of cognitive emotion regulation influence cognitive performance in IRCT20191228045922N1?
How does CER-based intervention compare to standard-of-care therapies for cognitive performance enhancement?
Which physiological biomarkers in IRCT20191228045922N1 predict response to cognitive emotion regulation training?
What adverse effects are observed in IRCT20191228045922N1's CER training and how are they managed?
Are there pharmacological agents that synergize with CER strategies to improve cognitive outcomes in this trial?